Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from IMGO

3 S&P 500 Stocks to Buy If You Like Winning

The economy proved resilient enough in 2023, as evidenced by recent strong economic reports. Following a brutal 2022, the S&P 500 has gotten a solid start this year and is expected to maintain the momentum. Hence, investors could consider buying fundamentally sound S&P 500 stocks Visa (V), Johnson & Johnson…

StockNews.com

3 Stocks It Is Time to Buy Now

Although headline inflation has slowed, the Fed will likely keep raising interest rates to attain its 2% target. However, a potential slowdown in monetary policy tightening is opening the path for quality stocks to recover. Therefore, investors should consider buying fundamentally sound stocks Merck & Co. (MRK), Novartis (NVS), and…

StockNews.com

The 3 Best Large-Cap Stocks to Buy Now and Hold Forever

Although the latest inflation and employment reports indicate a resilient economy, the Fed’s persistence to keep interest rates high has caused widespread concerns about an economic slowdown. With uncertainties surrounding the economy, we think it could be wise to buy and hold large-cap stocks Merck & Co. (MRK), Coca-Cola (KO),…

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Stocks to Help Protect Your Portfolio Through 2023

With the Fed likely to go ahead with its interest rate hikes this year, the market will likely remain under pressure. Given the foreseen volatility in the stock market, investors might consider investing in stable and dividend-paying stocks Merck & Co. (MRK), Elevance Health (ELV), and Waste Management (WM) to…

StockNews.com

The 3 Best Retirement Stocks to Buy for Investors Over 55

While moderation of the inflation rate is December has triggered a bear market rally, the stock market is unlikely to stabilize in the near term because of the likelihood of further interest rate hikes. Hence, shares of fundamentally strong and growing businesses with a track record of increasing dividend payouts,…

StockNews.com

3 Stocks to Buy Like There's No Tomorrow

While inflation eased considerably for two consecutive months, the Fed signaled to keep raising interest rates through this year. The potential continuation of rate hikes has fueled recessionary concerns. Amid an uncertain macroeconomic backdrop, it could be wise to buy fundamentally strong stocks Merck (MRK), Biogen (BIIB), and MasterCraft Boat…

StockNews.com

1 Pharma Stock That Could Head Even Higher Next Year

Pharma company Merck & Co. (MRK) is attempting to broaden its portfolio through collaborations and acquisitions. The company looks poised for growth in 2023. So, the stock might be a solid buy now. Read on….

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

Is Merck & Co. Stock Worth Buying Before the End of 2022?

Healthcare company Merck & Co. (MRK) is set to acquire Imago BioSciences (IMGO) for more than $1 billion. The stock has gained more than 40% this year. However, given the macroeconomic headwinds, would it be wise to buy the stock now? Read on to find out….

StockNews.com

4 Stocks to Buy That Have Caught Wall Street's Attention

With strong indications of slowing interest rate hikes by the Fed poised to feed the stock market rally, it could be wise to invest in Merck (MRK), AT&T (T), Mosaic (MOS), and Photronics (PLAB), which are in vogue on Wall Street. Continue reading….

StockNews.com

2 Stocks the Smart Money on Wall Street Owns the Majority Right Now

The Federal Reserve is expected to lower the pace of its rate hikes from next month. However, concerns about an economic slowdown are still evident. Hence, this might be the time to follow the smart money and buy Merck (MRK) and Yelp (YELP). Institutions own the majority of shares of…

StockNews.com

People

Mangeet Kaur BounsMangeet

595 stories

Santanu RoyHaving

215 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Medical Pharmaceuticals

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.